Biopharmaceutical Innovation & Optimization Center Scholarly Works
Browse by
Recent Submissions
-
Fosciclopirox suppresses growth of high-grade urothelial cancer by targeting the γ-secretase complex
(Springer Nature, 2021-05-31)Ciclopirox (CPX) is an FDA-approved topical antifungal agent that has demonstrated preclinical anticancer activity in a number of solid and hematologic malignancies. Its clinical utility as an oral anticancer agent, however, ... -
A phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax®) in patients with peritoneal malignancies
(Springer Verlag, 2015-05)PURPOSE: This multicenter, open-label, dose-escalating, phase I study evaluated the safety, tolerability, pharmacokinetics and preliminary tumor response of a nanoparticulate formulation of paclitaxel (Nanotax®) administered ...